Bert W. O'Malley, Jr., MD
Bert W. OMalley, Jr., MD is the Gabriel Tucker Professor and Chairman of the Department of Otorhinolaryngology Head & Neck Surgery. He is the Director of the Head and Neck Cancer Research Program, Co-Director of the Center for Head and Neck Cancer and Co-Director of the Center for Cranial Base Surgery, with joint appointments in the Departments of Neurosurgery and Radiation Oncology.
Dr. OMalley received his medical degree from the University of Texas Southwestern at Dallas. He completed two years of general surgery residency at the University of Texas Southwestern and Parkland Memorial Hospital and then a residency in Otolaryngology Head and Neck Surgery at Baylor College of Medicine. Dr. OMalley completed a fellowship in head and neck oncology and cranial base surgery at the University of Pittsburgh and subsequently began his academic faculty career at the Johns Hopkins University in 1995.
Dr. OMalley previously served as Professor and Chairman of the Division of Otolaryngology Head and Neck Surgery at the University of Maryland School of Medicine from February 1, 1999 through July of 2003 with joint appointments in the Department of Surgery and the Greenebaum Cancer Center. Prior to his appointment at Maryland, he held the position of Associate Professor and Director of Gene and Molecular Therapy in the Department of Otolaryngology Head & Neck Surgery at the Johns Hopkins School of Medicine.
Dr. OMalley brings clinical expertise in the area of skull base tumor surgery, head and neck and thyroid cancer and endoscopic sinus surgery. His clinical research focuses on the development of novel technologies such as image-guided surgery and robotic surgery. Dr. OMalley co-founded the first human robotics head and neck and skull base program in the world and is co-principal investigator of the first IRB approved human clinical trial for robotic surgery in the specialty. He is actively developing novel robotic surgical procedures (TORS) and instrumentation to advance the use of this technology in all aspects of Otolaryngology - Head and Neck Surgery. He was instrumental in the achievement of US FDA approval in December 2009 for TORS (Trans Oral Robotic Surgery).
Dr. OMalley is conducting laboratory research in the area of gene and molecular therapy, investigating both viral and non-viral based gene therapies for the treatment of head and neck cancer. The newest direction of this research is the use of molecular therapies to enhance the anti-tumor effects of chemotherapy and radiation while reducing the known toxicities of these treatments.
Board certified in Otolaryngology Head & Neck Surgery, Dr. OMalley is a Fellow of the American College of Surgeons and the International College of Surgeons. Dr. OMalley is a member of numerous professional societies, including the American Academy of Otolaryngology Head & Neck Surgery, the American Society of Head & Neck Surgery, the Triological Society, the American Laryngologic Society, the American BrochoEsophagology Society, the American Rhinologic Society, the Society of University Otolaryngologists Head & Neck Surgeons, The John Morgan Society, The Russian-American Cancer Alliance, The American College of Head and Neck Surgery, American Society for Gravitational and Space Biology and the Philadelphia County Medical Society. He is a founding member of the Cell Transplant Society and the Society of Robotic Surgery.
Dr. OMalley is Editor-in-Chief of the Journal for Oto-Rhino-Laryngology and Editor of the textbook Atlas of Skull Base Surgery.